The global Medical Enzyme Technology market was valued at USD 3.9 Billion in 2022 and it is anticipated to grow up to USD 7.7 Billion by 2032, at a CAGR of 7.0% during the forecast period.
Enzymes play a crucial role in the metabolic activities of all organisms, whether animal, human, plant, or microbial. They have an extensive range of applications in microbial biotechnology and diagnosis processes. The abnormality of the enzyme metabolism system leads to many metabolic diseases. Further, enzymes can be used as medicines to treat a range of diseases; they are called medicinal enzymes. For example, trypsin can be used not only to accelerate wound healing and dissolve blood clots but also to remove necrotic tissue and inhibit the proliferation of contaminating microorganisms. L-asparaginase can be used to treat cancer by depriving nutrients needed by the growth of cancer cells. Protease (like multi-enzyme tablets) can be used to treat dyspepsia, and it has an anti-inflammatory effect. Moreover, lipase, superoxide dismutase, nattokinase, soybean meal plasmin, and thrombin, among others, can be used to treat diseases.
Market Trends and Drivers
Rising demand for low cost and affordable, yet effective medical treatments, as well as rising prevalence of cancer, is estimated to fuel growth within the global medical enzyme technology market in coming years. Furthermore, rising focus of market players on research and development, as well as growing public awareness regarding benefits of these advanced treatment solutions is positively impacting growth within the global medical enzyme technology market.
Market Restraints and Challenges
The key restraints and challenges in Medical Enzyme Technology market are as follows:
Enzymes present some challenges, such as short in vivo half-life, lack of targeted action and, in particular, patient immune system reaction against the enzyme. For this reason, it is important to monitor serum immune response during treatment.
The report analyses the global Medical Enzyme Technology market based on enzyme, application, and region
Global Medical Enzyme Technology Market by Enzyme
Based on Enzyme, the market is segmented as Digestive Enzyme, Thrombolytic Enzyme, Hydrolases, and Others. The hydrolase segment held the largest revenue share of over xx% in 2022 Hydrolase enzymes possess the ability to accelerate the substrate's breakage. They also feature excellent catalyst effectiveness, broad specificity for substrates, are widely and commercially available, and showcase excellent stability. The hydrolases enzymes aid in treatment of several kind of disorders. Owing to their excellent properties, hydrolases enzyme products are expected to lead the global medical enzyme technology market in terms of demand in coming years.
Global Medical Enzyme Technology Market by Application
Based on application, the market is segmented as Disease Treatment, Diagnostic Tools, and Biomedical Research. The diagnostic tools segment accounted for the largest revenue share of over xx% in 2022. Products in the global medical enzyme technology market are widely used across diagnostic and pharmaceutical sectors. They are most commonly used as therapeutic agents in treatment of several disorders, most prominently ones caused by shortage of enzymes in the body. Furthermore, they are also used in various biotechnological, as well as diagnostic procedures, including sequencing and modification of DNA. Medical enzymes are also used in manufacture of several diagnostic testing solutions, such as ELISA.
Geographical Analysis of Global Medical Enzyme Technology Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America led the global medical enzyme technology market in 2022. The recent study forecasts that the same region will continue dominating the market over the next decade. This trend can be ascribed to increase in the incidence of chronic diseases, rising investments made by regional players for research and development, and increase in the demand for enzyme replacement therapies. Furthermore, the presence of a large number of well-established players also aids in the expansion of the North America medical enzyme technology market.
Asia Pacific is projected to display significant growth in the global medical enzyme technology market in coming years. Growing awareness amongst public, milestone achievements in biotechnology research, and growing acceptance of new technologically advanced solutions and advancements in medical technology, are some of the key drivers for this market. Furthermore, growing pharmaceutical output of the regional pharmaceutical manufacturers is also favoring growth within the Asia Pacific medical enzyme technology market.
Major Players in the Global Medical Enzyme Technology Market
The key players in the market are Merck KGaA, Thermo Fisher Scientific Inc., Novozymes, Takeda Pharmaceutical Company Limited, Agilent Technologies, Inc., Genzyme Corporation, Asahi Kasei Corporation, Promega Corporation, Cytiva, and Amano Enzyme Inc ., among others.
COVID-19 Impact:
The current pandemic outbreak of COVID-19 across the globe is further set to result in an exponential growth rate of this segment from 2020 to 2027. For instance, an Indian biotechnology company namely, Richcore Lifesciences is set to introduce 2pivotalenzyme components, applied largely across theCOVID-19 diagnostic kits based on Reverse Transcription Polymerase Chain Reaction (RT-PCR).
Also, a U.S. based manufacturer - Creative Enzymes has expanded the portfolio of healthcare specialty enzymes, acknowledging the present use of Nucleic Acid Test (NAT) and serological tests for COVID-19 diagnosis.
Recent Developments:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook